Clinical Features, Diagnosis, Treatment, and Prognosis of Heparin-Induced Bullous Hemorrhagic Dermatosis

Table 4

Treatment and prognosis of 72 patients with HBHD.

Parameters		Result
Treatment	Discontinued	44 (61.1%)
	Continued	20 (27.8%)
	Unspecified	7 (9.7%)
	Dose reduction	1 (1.4%)
	Switch to other anticoagulants	21 (29.2%)
	Oral anticoagulant	15 (20.8%)
	Fondaparinux	2 (2.8%)
	Other low molecular weight heparin	4 (5.6%)
	Rechallenge	1 (1.4%)
Outcome	Recovery	67 (93.1%)
	Unspecified	5 (6.9%)
	Death	4 (5.6%)
Time to resolution (46)^a	Days	14 (2, 141)^b

^aRepresents the number of patients out of 72 for whom information regarding this particular parameter was provided. ^bMedian (minimum-maximum).